Omar Casadiego
Omar Casadiego has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Aura Mantilla
Clinical Laboratory and Blood Bank Research Group, Higuera Escalante, Floridablanca, Colombia
1 shared publication- Fernando Rodríguez-Sanabria
Centro de Investigaciones en Enfermedades Tropicales, Departamento de Ciencias Básicas, Escuela de Medicina, Universidad Industrial de Santander, Piedecuesta, Colombia
1 shared publication - Guillermina Baay-Guzman
Unidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México Federico Gómez, México, D. F., México
1 shared publication Jennifer Castro
Clinical Laboratory and Blood Bank Research Group, Higuera Escalante, Floridablanca, Colombia
1 shared publication- Julio Cesar Mantilla
Departamento de Patología, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia
1 shared publication Laura Fernanda Neira Fuentes
Clinical Laboratory and Blood Bank Research Group, Higuera Escalante, Floridablanca, Colombia
1 shared publication
Latest Publications
- 17 October 2026
- Published by Springer Nature in Human Genetics
- Vol. 145 (1) , 89
Interobserver reliability and digital morphometric characterization of constitutional chromosomal heteromorphisms in clinical cytogenetics
Constitutional chromosomal heteromorphisms are common cytogenetic variants involving constitutive heterochromatin and acrocentric short-arm structures whose visual identification and classification remain challenging in routine cytogenetic practice. This study evaluated interobserver reliability in the visual classification of constitutional chromosomal heteromorphisms and characterized differences between homologous chromosomes using digital morphometry. A retrospective cross-sectional study included peripheral blood cytogenetic studies performed between 2021 and 2024. Sixty-six cases with previously reported heteromorphisms were included, yielding 73 heteromorphism observations. Four cytogeneticists, blinded to the original classification and clinical information, independently evaluated selected Q-banded metaphases using predefined visual criteria. Interobserver agreement was assessed using Krippendorff’s alpha and Gwet’s AC1. Digital morphometric analysis was performed in Fiji by measuring the chromosomal region associated with each heteromorphism, defined as the target region (TR), and calculating its absolute size and its ratio to total chromosome size (TR/T). Homologous chromosomes were compared using the Wilcoxon signed-rank test. Overall observed agreement was 70.1%, and complete agreement among the four cytogeneticists was observed in 45.5% of metaphases. Krippendorff’s alpha was 0.340 (95% CI 0.276–0.398), and Gwet’s AC1 was 0.453 (95% CI 0.380–0.532). Positive specific agreement was higher than negative specific agreement (77.1% vs. 56.9%). Significant morphometric asymmetry was identified in 11.0% of observations using absolute TR measurements and in 15.1% using TR/T. Findings for the acrocentric subgroup were based on only six observations and should be interpreted cautiously. Overall, visual classification showed limited reproducibility, particularly for pericentromeric heterochromatic variants. Digital morphometry provided complementary quantitative descriptors but did not resolve the limitations of classification based on chromosome morphology and should not be used as a confirmatory criterion.
- 17 October 2026
- Published by Springer Nature in Human Genetics
- Vol. 145 (1) , 89
Interobserver reliability and digital morphometric characterization of constitutional chromosomal heteromorphisms in clinical cytogenetics
Constitutional chromosomal heteromorphisms are common cytogenetic variants involving constitutive heterochromatin and acrocentric short-arm structures whose visual identification and classification remain challenging in routine cytogenetic practice. This study evaluated interobserver reliability in the visual classification of constitutional chromosomal heteromorphisms and characterized differences between homologous chromosomes using digital morphometry. A retrospective cross-sectional study included peripheral blood cytogenetic studies performed between 2021 and 2024. Sixty-six cases with previously reported heteromorphisms were included, yielding 73 heteromorphism observations. Four cytogeneticists, blinded to the original classification and clinical information, independently evaluated selected Q-banded metaphases using predefined visual criteria. Interobserver agreement was assessed using Krippendorff’s alpha and Gwet’s AC1. Digital morphometric analysis was performed in Fiji by measuring the chromosomal region associated with each heteromorphism, defined as the target region (TR), and calculating its absolute size and its ratio to total chromosome size (TR/T). Homologous chromosomes were compared using the Wilcoxon signed-rank test. Overall observed agreement was 70.1%, and complete agreement among the four cytogeneticists was observed in 45.5% of metaphases. Krippendorff’s alpha was 0.340 (95% CI 0.276–0.398), and Gwet’s AC1 was 0.453 (95% CI 0.380–0.532). Positive specific agreement was higher than negative specific agreement (77.1% vs. 56.9%). Significant morphometric asymmetry was identified in 11.0% of observations using absolute TR measurements and in 15.1% using TR/T. Findings for the acrocentric subgroup were based on only six observations and should be interpreted cautiously. Overall, visual classification showed limited reproducibility, particularly for pericentromeric heterochromatic variants. Digital morphometry provided complementary quantitative descriptors but did not resolve the limitations of classification based on chromosome morphology and should not be used as a confirmatory criterion.
- Open Access
- 20 August 2026
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 46 (3) , 393-408
Evaluation of the pro-healing effect of a commercial formulation of aqueous extract of Triticum vulgare in hyperglycemic mice
Introduction. Triticum vulgare extract, marketed as Fitostimoline™, is used to stimulate re-epithelialization and tissue regeneration. The use of this extract in chronic ulcers such as diabetic foot ulcers may represent a viable treatment alternative.Objective. To study the effects of 15% T. vulgare extract cream on wound healing in normoglycemic and streptozotocin-induced hyperglycemic BALB/c mice. Materials and methods. Hyperglycemia was induced in mice with a single dose of streptozotocin (200 mg/kg) (group STZ-1) or with multiple doses (30 mg/kg for five consecutive days) (group STZ-2). Excisional wounds were created on the dorsal skin, and T. vulgare extract was applied topically twice daily for ten days. We assessed wound closure, histological changes, and inflammatory markers.Results. Triticum vulgare extract treatment significantly enhanced wound closure in both normoglycemic and hyperglycemic mice compared to controls. Histological analysis revealed fewer mast cells, reduced inflammation in T. vulgare extract-treated groups, and increased collagen deposition in the treated normoglycemic and STZT-1 groups. Triticum vulgare extract treatment also reduced IL-6 and IL-1β levels in certain hyperglycemic groups.Conclusions. Overall, in this murine model, the topical application of T. vulgare extract improved wound healing in both normoglycemic and hyperglycemic conditions by accelerating closure, improving histological architecture, and rebalancing inflammatory cytokines toward a pro-healing profile, indicating its potential as a therapeutic option for diabetic wound care. The findings suggest multiple mechanisms of action for T. vulgare extract. Nonetheless, further research is necessary to elucidate these mechanisms and to fully explore potential clinical applications.
- 20 August 2026
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 46 (3) , 393-408
Open AccessEvaluation of the pro-healing effect of a commercial formulation of aqueous extract of Triticum vulgare in hyperglycemic mice
Introduction. Triticum vulgare extract, marketed as Fitostimoline™, is used to stimulate re-epithelialization and tissue regeneration. The use of this extract in chronic ulcers such as diabetic foot ulcers may represent a viable treatment alternative.Objective. To study the effects of 15% T. vulgare extract cream on wound healing in normoglycemic and streptozotocin-induced hyperglycemic BALB/c mice. Materials and methods. Hyperglycemia was induced in mice with a single dose of streptozotocin (200 mg/kg) (group STZ-1) or with multiple doses (30 mg/kg for five consecutive days) (group STZ-2). Excisional wounds were created on the dorsal skin, and T. vulgare extract was applied topically twice daily for ten days. We assessed wound closure, histological changes, and inflammatory markers.Results. Triticum vulgare extract treatment significantly enhanced wound closure in both normoglycemic and hyperglycemic mice compared to controls. Histological analysis revealed fewer mast cells, reduced inflammation in T. vulgare extract-treated groups, and increased collagen deposition in the treated normoglycemic and STZT-1 groups. Triticum vulgare extract treatment also reduced IL-6 and IL-1β levels in certain hyperglycemic groups.Conclusions. Overall, in this murine model, the topical application of T. vulgare extract improved wound healing in both normoglycemic and hyperglycemic conditions by accelerating closure, improving histological architecture, and rebalancing inflammatory cytokines toward a pro-healing profile, indicating its potential as a therapeutic option for diabetic wound care. The findings suggest multiple mechanisms of action for T. vulgare extract. Nonetheless, further research is necessary to elucidate these mechanisms and to fully explore potential clinical applications.